ACLARIS THERAPEUTICS INC. - COMMON STOCK

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

27 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

16 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

10 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics Provides Corporate Update

19 12 2023 15:01:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

05 12 2023 15:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

13 11 2023 08:45:10 提供 NetDania Notify

Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis and Provides Corporate Update

13 11 2023 06:00:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

06 11 2023 06:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

27 10 2023 15:01:18 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

26 10 2023 09:53:33 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

25 10 2023 08:46:06 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

24 10 2023 09:00:36 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

23 10 2023 10:04:04 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

19 10 2023 08:45:17 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

13 10 2023 08:45:04 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

12 10 2023 12:33:16 提供 NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

06 10 2023 08:53:45 提供 NetDania Notify

Aclaris Therapeutics Completes Enrollment in Phase 2b Study of ATI-1777 for Mild to Severe Atopic Dermatitis (ATI-1777-AD-202)

03 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference

20 9 2023 06:00:00 提供 Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor

18 9 2023 06:00:00 提供 Nasdaq GlobeNewswire